Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-30 |
filingDate |
2009-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2011-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6272343fe195d6395c3ab42126d0915 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4eef14cd3824b5dc759e072066fdf86b |
publicationDate |
2011-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7981892-B2 |
titleOfInvention |
Disubstituted phthalazine hedgehog pathway antagonists |
abstract |
The present invention provides novel 1,4-disubstituted phthalazine hedgehog pathway antagonists useful in the treatment of cancer. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9000023-B2 |
priorityDate |
2008-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |